Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03135847Enrolling by invitation
Using feedback to improve prosthetic movement in amputees
This study tests whether movement “feedback” can help adults with arm or leg amputations control a prosthetic better. It may be most helpful if you can comfortably wear a prosthetic socket and can understand and consent to the study.
Ages 18–75 - NCT05547698Recruiting
ECMO versus off-pump double lung transplant care
This study compares two ways of supporting the lungs and heart around the time of a double lung transplant: venoarterial ECMO versus an off-pump approach. It may help your team choose the safest support method based on your heart-lung pressures and surgical plan.
Louisville, KentuckyAges 18 years+ - NCT07672522Recruiting
Infections and the aging immune system in older adults
This study is looking at how infections and the aging immune system affect older adults. It compares people with an infection to healthy volunteers to understand how the body fights germs as we age.
Shanghai, Shanghai MunicipalityAges 60 years+ - NCT02265770RecruitingPhase 2/Phase 3
Treatment plan for children with brain ependymoma after surgery
This trial tests different follow-up treatments for children with brain ependymoma after their initial surgery. Which treatment you get depends on how much tumor is left (if any) and whether the child can safely receive radiation and chemotherapy.
GrazAges Up to 22 years - NCT07668271RecruitingPhase 4
HPV 9-valent vaccine lot consistency trial for women
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
Zhangping, FujianAges 18–30 - NCT06208410RecruitingPhase 1/Phase 2
JS105 plus other treatments for advanced solid tumors
This trial tests a new drug called JS105 combined with other anti-cancer therapies for people with certain advanced breast, ovarian, endometrial, or cervical cancers. It aims to find out if these combinations are safe and effective.
Zhengzhou, HenanAges 18–75 - NCT07666100Recruiting
Study of medication side effects in a periodontology clinic
This study looks at side effects from medications prescribed in a gum disease clinic. It aims to understand what types of side effects patients experience, which can help doctors choose safer medicines.
SivasAges 16 years+ - NCT06205602RecruitingPhase 2
HIV treatment with antibodies for a cure in Africa
This study tests if giving antibodies along with standard HIV medications can help control the virus without daily pills. It may lead to a functional cure for people living with HIV.
GaboroneAges 18–60 - NCT07659158Recruiting
Virtual resilience program for advanced cancer patients
This trial tests a virtual group program to help people with advanced cancer build resilience and manage stress. It involves online sessions and modules, and aims to improve coping and quality of life.
Rochester, MinnesotaAges 18 years+ - NCT06189963RecruitingPhase 1/Phase 2
Cell therapy trial for moderate Alzheimer's disease
This trial tests a new immune cell therapy (SNK01) for people with moderate Alzheimer's disease. The goal is to see if it can slow down memory and thinking decline.
Glendale, CaliforniaAges 40–85 - NCT03580785Recruiting
Study of delayed tooth eruption in children and teens
This study looks at how doctors diagnose delayed tooth eruption and how that affects treatment. It focuses on people with a condition called Primary Failure of Eruption (PFE) and tries to refine the best diagnostic checks.
StrasbourgAges 6 years+ - NCT06188624RecruitingPhase 1
Study of TQB2922 for advanced cancers
This trial tests a new drug, TQB2922, for people with advanced cancers that have not responded to standard treatments. The goal is to see if it is safe and how it affects the cancer.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT06157827RecruitingPhase 1/Phase 2
Testing LBL-024 plus chemo for advanced neuroendocrine carcinoma
This trial tests a new drug, LBL-024, combined with standard chemotherapy (etoposide and platinum) for people with advanced neuroendocrine carcinoma. The goal is to see if this combination works better than chemo alone.
Hefei, AnhuiAges 18–75 - NCT06160492RecruitingPhase 3
Testing a Glowing Dye to Improve Brain Tumor Removal
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
Guangzhou, GuangdongAges 18–70 - NCT00670735Recruiting
Research registry collecting data on hydrocephalus treatment
This study collects information about people with hydrocephalus when they have certain brain fluid (CSF) procedures. The goal is to better understand different patient groups and treatments across multiple centers.
Birmingham, AlabamaAges Up to 18 years - NCT03717441Recruiting
Study DNA from leftover IVF lab samples
This study looks at DNA found in leftover IVF lab materials to see if it can provide useful information during embryo screening. You might benefit indirectly by helping researchers test a less wasteful way to learn about embryos during IVF with chromosomal screening.
Lone Tree, ColoradoAges 18–44 - NCT07112209Enrolling by invitation
Rezvilutamide plus chemo for prostate cancer
This study tests a new combination treatment (Rezvilutamide plus docetaxel chemotherapy) for men with advanced prostate cancer that has stopped responding to abiraterone. The goal is to see if this combination can help control the cancer.
Guangzhou, GuangdongAges 18 years+ - NCT03037242Enrolling by invitation
Surgery outcomes for meniscus root tears with a specific repair technique
This study looks at results after a particular surgery to repair a meniscus root tear in the knee. It may help doctors understand which patients benefit most and what outcomes to expect.
Rochester, MinnesotaAges 18–65 - NCT07165769RecruitingPhase 2
ZGR combo for newly diagnosed spleen lymphoma with large cells
This trial tests a combination of three drugs (zanubrutinib, obinutuzumab, and lenalidomide) for people newly diagnosed with splenic B-cell lymphoma that has large cells (prominent nucleoli). The goal is to see if this drug combination is safe and effective.
Tianjin, Tianjin MunicipalityAges 18–80 - NCT02613546Recruiting
Cognitive therapy for sexual difficulties in women
This trial studies whether cognitive behavioral therapy (a structured talk-therapy approach) can improve sexual problems. You may be eligible if your sexual function score is low, but not if you have moderate or severe depression/anxiety symptoms or start hormone therapy after beginning the group sessions.
Salvador, Estado de BahiaAges 18–59 - NCT07108920Recruiting
Balance and Botox for Stiff Knee Gait
This study tests whether botulinum toxin (Botox) injections into the rectus femoris thigh muscle can improve balance and walking in people with a stiff knee gait (a common problem after stroke, brain injury, or multiple sclerosis).
Héricourt, Nord Franche-ComtéAges 18 years+ - NCT07120906Recruiting
Augmented reality guidance for MRI liver procedures
This study tests a new augmented reality system to help doctors place needles in the liver during MRI scans for biopsies or ablation (heat to destroy tumors). The goal is to see if it improves accuracy and speed.
Jacksonville, FloridaAges 18–90 - NCT03475498Recruiting
ECG and heart ultrasound before and after pacemaker implantation
This study looks at how heart test results—electrical tracing (ECG) and heart ultrasound (echocardiogram)—change after a device is implanted. It may help doctors better predict who develops PICM (a certain pacing-related heart weakening) and how that affects outcomes.
ChungjuAges 20 years+ - NCT03225677Recruiting
Testing a new scan to study muscle breakdown in cirrhosis
This study looks at how your body uses protein in your muscles when you have cirrhosis (a scarred liver). It uses a special “tracer” method (a substance that can be tracked) and may help researchers better understand muscle loss in people with milder cirrhosis.
Cleveland, OhioAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.